Outcome of the Board Meeting held on 02.01.2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.6 pts more than Nifty Microcap 250 and 4.9 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board of Jeevan Scientific Technology, at its meeting on 02 January 2026, approved two preferential allotments. First, 35 lakh convertible warrants were allotted at Rs.40 each (aggregating Rs.14 crore) to promoters (Krishna Kishore Kuchipudi, K Vanaja, Jeevan Krishna Kuchipudi, Snigdha Mothukuri) and non-promoter Decibels Properties Pvt Ltd. The company has already received 25% upfront (Rs.10 per warrant, total Rs.3.5 crore). Second, 40.85 lakh equity shares of Rs.10 face value were allotted at Rs.40 per share (Rs.30 premium), aggregating Rs.16.34 crore, to 23 non-promoter allottees. The largest non-promoter recipients include Padmaja Private Trust (15 lakh shares), Alpha Financials (5 lakh), and Shradha Bangad (4 lakh). Combined, the company is raising up to Rs.30.34 crore from these preferential issues.
This results in significant equity dilution for existing shareholders, though promoter participation (taking 30 lakh warrants) signals insider confidence in the company's prospects. Short-term share price may face pressure due to the large preferential issue at Rs.40, while the convertible nature of warrants means further dilution is possible if they are exercised.